Published in Am J Clin Nutr on January 01, 2005
The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int (2016) 1.25
Effects of average childhood dairy intake on adolescent bone health. J Pediatr (2008) 0.83
Racial difference in the correlates of bone mineral content/density and age at peak among reproductive-aged women. Osteoporos Int (2009) 0.78
Calcium revisited: part II calcium supplements and their effects. Bonekey Rep (2014) 0.75
Statins and the risk of colorectal cancer. N Engl J Med (2005) 6.86
Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet (2008) 6.75
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet (2010) 4.96
Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet (2007) 4.69
Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med (2007) 4.25
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet (2007) 3.63
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet (2008) 3.41
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2002) 3.25
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J Natl Cancer Inst (2008) 2.78
Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis. J Bone Miner Res (2009) 2.48
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35
Use of bisphosphonates and risk of postmenopausal breast cancer. J Clin Oncol (2010) 2.33
Genetic variation in 8q24 associated with risk of colorectal cancer. Cancer Biol Ther (2007) 2.32
A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet (2002) 2.24
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet (2009) 2.13
Vitamin D status in primary hyperparathyroidism. Eur J Intern Med (2011) 2.05
Tests for gene-environment interaction from case-control data: a novel study of type I error, power and designs. Genet Epidemiol (2008) 2.04
BLM heterozygosity and the risk of colorectal cancer. Science (2002) 2.03
Clinical phenotype of families with longevity. J Am Geriatr Soc (2004) 2.03
Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol (2003) 1.97
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res (2010) 1.90
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet (2013) 1.88
Use of bisphosphonates and reduced risk of colorectal cancer. J Clin Oncol (2011) 1.84
BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst (2004) 1.76
Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat (2008) 1.76
The relationship between serum 25(OH)D and parathyroid hormone levels. Am J Med (2011) 1.70
MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers. Cancer Res (2011) 1.68
Does the modern urbanized sleeping habitat pose a breast cancer risk? Chronobiol Int (2011) 1.63
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet (2010) 1.56
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer (2005) 1.48
Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer. Cancer Prev Res (Phila) (2010) 1.45
Vitamin D deficiency in oncology patients--an ignored condition: impact on hypocalcemia and quality of life. Isr Med Assoc J (2012) 1.42
Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study. CMAJ (2011) 1.38
Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment. J Bone Miner Res (2005) 1.33
Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.31
The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer. Nat Genet (2004) 1.25
Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol (2009) 1.23
The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prev (2008) 1.22
FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations. Cancer Epidemiol Biomarkers Prev (2008) 1.22
Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates. Nat Rev Clin Oncol (2013) 1.20
Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework. Am J Pathol (2003) 1.20
Compliance of osteoporotic patients with different treatment regimens. Isr Med Assoc J (2003) 1.17
Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim. Am J Hum Genet (2003) 1.16
Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway. Clin Cancer Res (2009) 1.15
BRCA germline mutations in Jewish women with uterine serous papillary carcinoma. Gynecol Oncol (2004) 1.14
A case-control study of levothyroxine and the risk of colorectal cancer. J Natl Cancer Inst (2010) 1.14
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol (2011) 1.12
Use of hormone replacement therapy and the risk of colorectal cancer. J Clin Oncol (2009) 1.11
Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer (2012) 1.07
Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients. Cancer (2011) 1.03
Gene expression differences between colon and rectum tumors. Clin Cancer Res (2011) 1.03
The effect of statins on risk and survival of gynecological malignancies. Gynecol Oncol (2013) 1.03
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res (2006) 1.01
Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer Causes Control (2010) 0.98
K-ras mutations in sporadic colorectal tumors in Israel: unusual high frequency of codon 13 mutations and evidence for nonhomogeneous representation of mutation subtypes. Dig Dis Sci (2002) 0.97
Vascular disorders preceding diagnosis of cancer: distinguishing the causal relationship based on Bradford-Hill guidelines. Angiology (2003) 0.95
The risk of all-cause mortality is inversely related to serum 25(OH)D levels. J Clin Endocrinol Metab (2012) 0.94
MutYH mutation carriers have increased breast cancer risk. Cancer (2011) 0.93
CDX2 polymorphisms, RNA expression, and risk of colorectal cancer. Cancer Res (2005) 0.91
Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBioMedicine (2015) 0.90
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst (2015) 0.90
Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO). Cancer Causes Control (2011) 0.89
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res (2014) 0.89
Standardized versus individualized parenteral nutrition in very low birth weight infants: a comparative study. Neonatology (2010) 0.89
RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients. Cancer Epidemiol Biomarkers Prev (2006) 0.88
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat (2007) 0.88
Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible? J Natl Cancer Inst (2005) 0.88
Vitamin D and calcium-sensing receptor genotypes in men and premenopausal women with low bone mineral density. Isr Med Assoc J (2002) 0.87
FOXP3 germline polymorphisms are not associated with risk of breast cancer. Cancer Genet Cytogenet (2009) 0.87
Physical activity and bone mineral density in adolescents with vitamin D deficiency. Med Sci Sports Exerc (2010) 0.87
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Hum Genet (2011) 0.87
The association between obesity and urinary tract infection. Eur J Intern Med (2012) 0.86
Clustering women's health behaviors. Health Educ Behav (2002) 0.86
Excellent performance of Hemoccult Sensa in organised colorectal cancer screening. Eur J Cancer (2012) 0.86
Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use. Cancer (2010) 0.85
The longitudinal variability of serum 25(OH)D levels. Eur J Intern Med (2012) 0.85
Treatment preference and tolerability with alendronate once weekly over a 3-month period: an Israeli multi-center study. Aging Clin Exp Res (2005) 0.85
Colorectal polyps in carriers of the APC I1307K polymorphism. Dis Colon Rectum (2005) 0.84
Calcium supplementation provides an extended window of opportunity for bone mass accretion after menarche. Am J Clin Nutr (2003) 0.84
Quality control in a National Program for the Early Detection of Breast Cancer: women's satisfaction with the mammography process. Womens Health Issues (2008) 0.84
Low integrated DNA repair score and lung cancer risk. Cancer Prev Res (Phila) (2013) 0.83
N-methylpurine DNA glycosylase and OGG1 DNA repair activities: opposite associations with lung cancer risk. J Natl Cancer Inst (2012) 0.83
The use of exercise stress testing for the management of low-risk patients with chest pain. Am J Emerg Med (2009) 0.83
Polymorphisms in alcohol metabolism genes ADH1B and ALDH2, alcohol consumption and colorectal cancer. PLoS One (2013) 0.82
A controlled intervention study of changing health-providers' attitudes toward personal lifestyle habits and health-promotion skills. Nutrition (2009) 0.82
Adherence to vitamin D supplementation in elderly patients after hip fracture. J Am Geriatr Soc (2004) 0.82